Showing results (811-820 of 2,229) with videos related to

Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
Characterization of a radiolabeled small molecule targeting leukocyte function-associated antigen-1 expression in lymphoma and leukemiaRahul B Poria, Jeffrey P Norenberg, Tamara L Anderson, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2Walter D Y Quan, Paul R Walker, Francine M Quan, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancerPatrizia Pellegrini, Anna Maria Berghella, Ida Contasta, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
Lanthanide-loaded liposomes for multimodality imaging and therapySander W Zielhuis, Jan-Henry Seppenwoolde, Vanessa A P Mateus, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Renaissance of targeting molecules for melanomaEkaterina Dadachova, Arturo Casadevall
Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Pharmacokinetics of the photosensitizers aminolevulinic acid and aminolevulinic acid hexylester in oro-facial tumors embedded in the chorioallantois membrane of a hen's eggChristian Hoppenheit, Dirk Hüttenberger, Hans-Jochen Foth, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Direct antilymphoma activity of novel, first-generation "antibody mimics" that bind HLA-DR10-positive non-Hodgkin's lymphoma cellsJeremy West, Julie Perkins, Saphon Hok, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
The potential use of 99mTc-MDP bone scans to plan high-activity 186Re-HEDP targeted therapy of bony metastases from prostate cancerDavid Binnie, Antigoni Divoli, V Ralph McCready, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastomaMark N Gaze, Yen-Ch'ing Chang, Glenn D Flux, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumorsGabriele Pöpperl, Thomas Helmberger, Wolfgang Münzing, et al.
Pageof 223